Ventas, Inc.

Ventas, Inc. (VTR) Market Cap

Ventas, Inc. has a market capitalization of $39.09B.

Financials based on reported quarter end 2025-12-31

Price: $82.22

β–² 2.12 (2.65%)

Market Cap: 39.09B

NYSE Β· time unavailable

CEO: Debra A. Cafaro

Sector: Real Estate

Industry: REIT - Healthcare Facilities

IPO Date: 1997-05-05

Website: https://www.ventasreit.com

Ventas, Inc. (VTR) - Company Information

Market Cap: 39.09B Β· Sector: Real Estate

Ventas, an S&P 500 company, operates at the intersection of two powerful and dynamic industries: healthcare and real estate. As one of the world's foremost Real Estate Investment Trusts (REIT), we use the power of capital to unlock the value of real estate, partnering with leading care providers, developers, research and medical institutions, innovators and healthcare organizations whose success is buoyed by the demographic tailwind of an aging population. For more than twenty years, Ventas has followed a successful strategy that endures: combining a high-quality diversified portfolio of properties and capital sources to manage through cycles, working with industry leading partners, and a collaborative and experienced team focused on producing consistent growing cash flows and superior returns on a strong balance sheet, ultimately rewarding Ventas shareholders. As of September 30, 2020, Ventas owned or managed through unconsolidated joint ventures approximately 1,200 properties.

Analyst Sentiment

68%
Buy

Based on 32 ratings

Analyst 1Y Forecast: $85.88

Average target (based on 4 sources)

Consensus Price Target

Low

$85

Median

$90

High

$100

Average

$90

Potential Upside: 9.9%

Price & Moving Averages

Loading chart...

πŸ“˜ Full Research Report

ℹ️

AI-Generated Research: This report is for informational purposes only.

πŸ“˜ Ventas, Inc. (VTR) β€” Investment Overview

🧩 Business Model Overview

Ventas, Inc. operates as a leading real estate investment trust (REIT) focused primarily on the healthcare sector. Its core business is the ownership and management of healthcare-related properties, such as senior housing communities, medical office buildings, research and innovation centers, inpatient rehabilitation facilities, and hospitals. Ventas partners with a diversified mix of tenants, operators, and healthcare providers, serving a broad spectrum of seniors, medical professionals, and patients. The company operates across North America and has a presence in major metropolitan areas, allowing it to benefit from demographic and population trends impacting the healthcare industry.

πŸ’° Revenue Model & Ecosystem

Ventas derives revenue primarily through contractual lease agreements and property management with healthcare operators and tenants. Its income streams include triple-net leases, where tenants assume most property-related expenses, as well as management contracts for senior housing and partnerships in joint ventures. The company’s portfolio blends stable, long-term lease revenues from medical office buildings and hospitals with variable income from operating senior living facilities. By aligning with both enterprise-scale healthcare systems and regional service providers, Ventas maintains a balanced exposure within the broader healthcare ecosystem. The company also leverages asset management and development services, supporting ongoing value creation within its portfolio.

🧠 Competitive Advantages

  • Brand strength: Ventas holds a reputation as a premier healthcare REIT, underpinned by a longstanding track record, credibility with institutional investors, and trusted relationships with healthcare operators.
  • Switching costs: The nature of healthcare facility operations and long-term leases fosters significant stickiness, with tenants and operators less likely to relocate due to regulatory, capital expenditure, and occupancy considerations.
  • Ecosystem stickiness: Ventas’s integrated network of medical and senior living properties creates synergies, making it a partner of choice for healthcare organizations seeking scale, geographic reach, and deep sector expertise.
  • Scale + supply chain leverage: The company’s broad portfolio and national scale offer purchasing power, risk diversification, and the ability to secure attractive financing and development opportunities.

πŸš€ Growth Drivers Ahead

The primary drivers for future growth include demographic trends such as the aging population, increasing demand for senior care and outpatient medical services, and intensifying focus on health and wellness real estate. Ventas is positioned to capitalize on the expansion of senior housing needs, as well as the shift toward outpatient and ambulatory care that increases demand for modern medical office buildings. Strategic portfolio expansion through acquisitions, development of new facilities, and partnerships with leading healthcare operators support ongoing asset and earnings growth. Additionally, investments in research and innovation centers align the company with technological evolution in healthcare delivery.

⚠ Risk Factors to Monitor

Key risks include evolving regulatory oversight of healthcare real estate, potential shifts in reimbursement policy, and exposure to changes in government healthcare funding. Market competition remains notable, both among other healthcare REITs and traditional real estate players seeking entry. Margin pressures could arise from rising costs, operator health, or temporary oversupply conditions within certain property types. The pace of technological disruption in healthcare delivery and changes in consumer preferences also present longer-term uncertainties that could impact property demand or operating models.

πŸ“Š Valuation Perspective

Ventas is often valued by the market in line with, or at a modest premium to, diversified healthcare REIT peers, reflecting its high-quality asset base and established operator relationships. Factors influencing its relative valuation include property mix, geographic footprint, portfolio age, and management’s track record for disciplined capital allocation. Investors tend to assess Ventas with a focus on its growth potential, resilience of cash flows, and ability to maintain stable occupancy rates across market cycles.

πŸ” Investment Takeaway

Ventas offers investors exposure to demographic-driven secular growth themes within healthcare and senior living, supported by strong industry relationships and a diversified property portfolio. The bull case centers around accelerating demand for care infrastructure and the company’s ability to capture value through scale, operational expertise, and strategic expansion. The bear case highlights potential headwinds from regulatory changes, competitive pressure, operator health, and shifting macroeconomic or healthcare trends. Careful monitoring of portfolio performance and evolving industry dynamics will remain essential for prospective investors.


⚠ AI-generated research summary β€” not financial advice. Validate using official filings & independent analysis.

Fundamentals Overview

Loading fundamentals overview...

πŸ“Š AI Financial Analysis

Powered by StockMarketInfo
Earnings Data: Q Ending 2025-12-31

"For the quarter ending December 31, 2025, VTR reported a revenue of $1.57 billion, with net income totaling $70.2 million, which translates to an EPS of $0.15. The company's net margin stands at approximately 4.5%. The free cash flow for the previous quarter was recorded at $286.4 million. Over the past year, revenue growth and profitability trends show a stable trajectory, supported by consistent free cash flow generation. VTR maintains a debt-to-equity ratio implying substantial leverage, yet total equity remains robust. Operating cash flow reflects sufficient liquidity to cover capital expenditures and dividend commitments. Despite not repurchasing shares, dividends have been regularly paid, with the latest being $0.52 per share. Analyst sentiment suggests a moderate valuation with a consensus price target of $84.75. Current market metrics should be monitored as the price changes over the last year may influence investor sentiment."

Revenue Growth

Positive

Revenue shows steady growth; however, it's reliant on macroeconomic factors and sector trends.

Profitability

Neutral

Operating margins are positive, with EPS demonstrating an uptrend, but efficiency improvements potential exist.

Cash Flow Quality

Good

Consistent free cash flow supports capital allocation priorities, including dividends.

Leverage & Balance Sheet

Neutral

High net debt, but the balance sheet shows resilience through solid equity levels.

Shareholder Returns

Positive

Dividends are consistently grew and returning value to shareholders; absence of buybacks noted.

Analyst Sentiment & Valuation

Positive

Analysts hold a moderate outlook, with valuation targets suggesting potential upside.

Disclaimer:This analysis is AI-generated for informational purposes only. Accuracy is not guaranteed and this does not constitute financial advice.

Ventas delivered a strong Q4 and FY25 with double-digit SHOP NOI growth, rising occupancy and margins, and 9–10% FFO/share growth. The company is leaning into compelling senior housing supply/demand dynamics, expanding through $2.5B of 2025 acquisitions and targeting another $2.5B in 2026. Guidance calls for high single-digit FFO growth and a fifth year of double-digit SHOP NOI gains, supported by pricing, occupancy, and operating leverage. Balance sheet strength improved with lower leverage, substantial funding capacity, and an 8% dividend increase. Management’s tone was confident, while acknowledging near-term weather costs, higher refinancing expense, and competitive acquisition markets.

Growth

  • FY25 normalized FFO/share up 9% to $3.48; Q4 normalized FFO/share up 10% y/y
  • FY25 SHOP same-store cash NOI up 15% (4th straight year of double-digit growth)
  • Q4 SHOP: revenue up >8% y/y; occupancy +300 bps y/y (+100 bps seq); RevPOR +4.7%; NOI +15.4% y/y; margin +180 bps to >28%
  • Q4 total company same-store property growth +8% y/y
  • Q4 OMAR same-store cash NOI up ~4%; outpatient medical occupancy ~91% (6 straight quarters of y/y gains)
  • 2026 guide: normalized FFO/share $3.78–$3.88 (midpoint +8%); total company same-store cash NOI nearly +10%
  • 2026 SHOP same-store NOI +13%–17% (midpoint +15%) with +270 bps occupancy and +5% RevPOR; OMAR ~+2.5%; Triple-net >+4%

Business Development

  • Closed $2.5B of senior housing acquisitions in 2025; >$800M closed YTD 2026 across 7 transactions
  • 2026 investment target: $2.5B focused on senior housing; pipeline described as highly active
  • Transitioned 45 former Brookdale communities from triple-net to SHOP; now with 5 operators; capital refresh underway
  • Expanded SHOP to >83,000 units; 53% of NOI from SHOP
  • Deal sourcing leverages relationships: >70% of transactions since 2024 with existing operator partners; >50% with repeat sellers
  • Targeting low double-digit to mid-teens unlevered IRRs on senior housing investments

Financials

  • Enterprise value exceeded $50B
  • Q4 annualized NOI ~$2.5B; SHOP NOI ~$1.3B
  • Leverage 5.2x at Q4 (best since 2012); pro forma for unsettled forward equity approaching ~5x; trend lower expected in 2026
  • 2026 net income guidance midpoint $0.57/share
  • 2026 normalized FFO/share guidance midpoint $3.83 (+8% y/y on comparable basis)
  • Beginning 2026, normalized FFO excludes noncash stock-based comp (impact ~$0.08/share in both 2025 and 2026; no effect on growth rate)
  • 2026 G&A (cash) expected in low $150M range

Capital & Funding

  • Raised >$7B since start of 2025: nearly $4B in bank, bonds and mortgage debt; $3.2B equity issuance
  • Significant unsettled forward equity available to fund investments; supports lower leverage trajectory
  • Board approved an 8% increase in the quarterly dividend
  • Capital allocation priority remains U.S. senior housing

Operations & Strategy

  • Executing 1-2-3 Strategy: outsized SHOP organic growth; value-creating senior housing investments; drive cash flow across portfolio
  • Ventas Operational Insights platform deepened with operators; tech-agnostic; focus on pricing, sales execution, benchmarking and NOI-driving CapEx
  • U.S. SHOP occupancy at ~86%, providing runway; top 99 U.S. markets outperformed NIC by 160 bps
  • Network of 43 SHOP operators enables matching of communities to best-in-class operators
  • Expect continued margin expansion in 2026; modestly higher 1Q expenses from severe weather incorporated

Market & Outlook

  • Demographics turning favorable: baby boomers begin turning 80; 80+ population expected to rise 28% in 5 years and double over 20 years
  • Supply constrained: ~2,500 new units started in Q4 2025 vs ~2 million people turning 80 in 2026
  • Expect a fifth consecutive year of double-digit SHOP NOI growth in 2026
  • Active acquisition pipeline; competition increasing but company cites advantaged access via scale, relationships and operating expertise

Risks Or Headwinds

  • Severe winter weather driving higher near-term operating expenses (Q1 2026)
  • Increased competition for senior housing assets may pressure acquisition yields
  • Higher net interest expense expected from refinancing maturing debt in 2026
  • Expiration of noncash rental income from Brookdale is a headwind to 2026 FFO (partly offset by triple-net cash rent increases)

Sentiment: POSITIVE

Note: This summary was synthesized by AI from the VTR Q4 2025 earnings transcript. Financial data is complex; please verify all metrics against official SEC filings before making investment decisions.

Loading financial data and tables...
πŸ“

SEC Filings (VTR)

Β© 2026 Stock Market Info β€” Ventas, Inc. (VTR) Financial Profile